Cargando…

From the tyrosine hydroxylase hypothesis of Parkinson’s disease to modern strategies: a short historical overview

A time span of 60 years covers the detection of catecholamines in the brain, their function in movement and correlation to Parkinson’s disease (PD). The clinical findings that orally given l-DOPA can alleviate or even prevent akinesia gave great hope for the treatment of PD. Attention focused on the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rausch, Wolf-Dieter, Wang, Feixue, Radad, Khaled
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2022
Materias:	Neurology and Preclinical Neurological Studies - Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188506/ https://www.ncbi.nlm.nih.gov/pubmed/35460433 http://dx.doi.org/10.1007/s00702-022-02488-3

Ejemplares similares

The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson’s disease
por: Nagatsu, Toshiharu, et al.
Publicado: (2023)

Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes
por: Wulf, Maximilian, et al.
Publicado: (2022)

Modern Brainstem MRI Techniques for the Diagnosis of Parkinson's Disease and Parkinsonisms
por: Arribarat, Germain, et al.
Publicado: (2020)

An Overview of the Relationship Between Occupational Manganese Exposure and Parkinsonism
por: Dirandeh, Elham, et al.
Publicado: (2022)

Impulse Control Disorders and Dopamine-Related Creativity: Pathogenesis and Mechanism, Short Review, and Hypothesis
por: Garcia-Ruiz, Pedro J.
Publicado: (2018)

Effectiveness of Acupuncture in the Treatment of Parkinson's Disease: An Overview of Systematic Reviews
por: Huang, Jinke, et al.
Publicado: (2020)

Motor and non-motor improvements following short-term multidisciplinary day-clinic care in Parkinson´s disease
por: Krause, Patricia, et al.
Publicado: (2022)

Optical Coherence Tomography to Assess Neurodegeneration in Phenylalanine Hydroxylase Deficiency
por: Lotz-Havla, Amelie S., et al.
Publicado: (2021)

Tympanic Resonance Hypothesis
por: Boedts, Michael J. O.
Publicado: (2020)

Short- and Long-Term Effects of DBS on Gait in Parkinson's Disease
por: Brozova, Hana, et al.
Publicado: (2021)

Viruses, parkinsonism and Parkinson’s disease: the past, present and future
por: Leta, Valentina, et al.
Publicado: (2022)

The toxic metal hypothesis for neurological disorders
por: Pamphlett, Roger, et al.
Publicado: (2023)

The heterogeneity of Parkinson’s disease
por: Wüllner, Ullrich, et al.
Publicado: (2023)

A historical review of multiple system atrophy with a critical appraisal of cellular and animal models
por: Marmion, David J., et al.
Publicado: (2021)

New therapeutic hypothesis for infantile extrinsic hydrocephalus
por: Kameda, Masahiro, et al.
Publicado: (2023)

Glucocerebrosidase mutations and Parkinson disease
por: Vieira, Sophia R. L., et al.
Publicado: (2022)

Life style and Parkinson’s disease
por: Reichmann, Heinz, et al.
Publicado: (2022)

Multi-Dimensional, Short-Timescale Quantification of Parkinson's Disease and Essential Tremor Motor Dysfunction
por: Sanderson, John B., et al.
Publicado: (2020)

Bulat-Klarica-Oreskovic Hypothesis: A Comprehensive Review
por: Bajda, Joe, et al.
Publicado: (2023)

The dual-path hypothesis for the emergence of anosognosia in Alzheimer’s disease
por: Andrade, Katia, et al.
Publicado: (2023)

Treatment of Parkinson’s disease in the advanced stage
por: Ossig, C., et al.
Publicado: (2013)

Small intestine dysfunction in Parkinson’s disease
por: Dutkiewicz, Justyna, et al.
Publicado: (2015)

Neuroprotection in Parkinson’s disease: facts and hopes
por: Salamon, András, et al.
Publicado: (2019)

Overview of MR Image Segmentation Strategies in Neuromuscular Disorders
por: Ogier, Augustin C., et al.
Publicado: (2021)

Historical Perspective and Medical Maladies of Alexander the Great
por: Mishra, Shri K, et al.
Publicado: (2022)

Sleep and non-motor symptoms in Parkinson’s disease
por: Maass, Antonia, et al.
Publicado: (2013)

Parkinson’s disease between internal medicine and neurology
por: Csoti, Ilona, et al.
Publicado: (2015)

Magnetic resonance imaging for the diagnosis of Parkinson’s disease
por: Heim, Beatrice, et al.
Publicado: (2017)

Implications of dopaminergic medication withdrawal in Parkinson’s disease
por: Koschel, J., et al.
Publicado: (2021)

Disease modification in Parkinsonism: obstacles and ways forward
por: Höllerhage, M., et al.
Publicado: (2022)

Genetic testing for Parkinson’s disease in clinical practice
por: Gasser, Thomas
Publicado: (2023)

The use of wearables for the diagnosis and treatment of Parkinson’s disease
por: Reichmann, Heinz, et al.
Publicado: (2023)

Blood neurofilament light chain in Parkinson’s disease
por: Buhmann, Carsten, et al.
Publicado: (2023)

Parkinson’s disease therapy: what lies ahead?
por: Wolff, Andreas, et al.
Publicado: (2023)

Non-motor symptoms of Parkinson’s disease: the patient’s perspective
por: Breen, Kieran C., et al.
Publicado: (2012)

Flavor perception and the risk of malnutrition in patients with Parkinson’s disease
por: Roos, Dareia S., et al.
Publicado: (2018)

Parkinson’s: a syndrome rather than a disease?
por: Titova, Nataliya, et al.
Publicado: (2016)

Diagnostic accuracy of glabellar tap sign for Parkinson’s disease
por: Nuuttila, Simo, et al.
Publicado: (2021)

The pathobiological basis of depression in Parkinson disease: challenges and outlooks
por: Jellinger, Kurt A.
Publicado: (2022)

Gender differences in non-motor fluctuations in Parkinson’s disease
por: Donzuso, Giulia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mbo1f1d6lbu6c18odq228e9mdm